These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 2528491

  • 1. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
    Serradas P, Bailbé D, Portha B.
    Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
    [Abstract] [Full Text] [Related]

  • 2. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
    Portha B, Serradas P.
    Am J Med; 1991 Jun 24; 90(6A):15S-21S. PubMed ID: 1831320
    [Abstract] [Full Text] [Related]

  • 3. Abnormal B-cell function in rats with non-insulin-dependent diabetes induced by neonatal streptozotocin: effect of in vivo insulin, phlorizin, or vanadate treatments.
    Serradas P, Bailbé D, Blondel O, Portha B.
    Pancreas; 1991 Jan 24; 6(1):54-62. PubMed ID: 1994380
    [Abstract] [Full Text] [Related]

  • 4. Effect of gliclazide treatment on insulin secretion and beta-cell mass in non-insulin dependent diabetic Goto-Kakisaki rats.
    Dachicourt N, Bailbé D, Gangnerau MN, Serradas P, Ravel D, Portha B.
    Eur J Pharmacol; 1998 Nov 20; 361(2-3):243-51. PubMed ID: 9865514
    [Abstract] [Full Text] [Related]

  • 5. Comparison of beta-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats.
    Kawai K, Suzuki S, Murayama Y, Watanabe Y, Yamashita K.
    Diabetes Res Clin Pract; 1991 Jul 20; 12(3):163-72. PubMed ID: 1832376
    [Abstract] [Full Text] [Related]

  • 6. Characteristic features of insulin secretion in the streptozotocin-induced NIDDM rat model.
    Tsuji K, Taminato T, Usami M, Ishida H, Kitano N, Fukumoto H, Koh G, Kurose T, Yamada Y, Yano H.
    Metabolism; 1988 Nov 20; 37(11):1040-4. PubMed ID: 3054430
    [Abstract] [Full Text] [Related]

  • 7. Impaired in vivo insulin secretion in response to non-glucidic secretagogues in adult rats after neonatal streptozotocin.
    Vicent D, Villanueva-Peñacarrillo ML, Valverde I, Malaisse WJ.
    Acta Diabetol; 1994 Sep 20; 31(3):133-7. PubMed ID: 7827350
    [Abstract] [Full Text] [Related]

  • 8. Characteristics of pancreatic beta-cell secretion in Type 2 diabetic patients treated with gliclazide and glibenclamide.
    van der Wal PS, Heine RJ.
    Diabetes Res Clin Pract; 2001 May 20; 52(2):103-11. PubMed ID: 11311964
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Glucagon, insulin and somatostatin secretion in response to sympathetic neural activation in streptozotocin-induced diabetic rats. A study with the isolated perfused rat pancreas in vitro.
    Kurose T, Tsuda K, Ishida H, Tsuji K, Okamoto Y, Tsuura Y, Kato S, Usami M, Imura H, Seino Y.
    Diabetologia; 1992 Nov 20; 35(11):1035-41. PubMed ID: 1361917
    [Abstract] [Full Text] [Related]

  • 11. Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment.
    Inoue K, Hisatomi A, Umeda F, Nawata H.
    Diabetes; 1992 Jun 20; 41(6):723-7. PubMed ID: 1534057
    [Abstract] [Full Text] [Related]

  • 12. Diazoxide infusion at excess but not at basal hyperglycemia enhances beta-cell sensitivity to glucose in vitro in neonatally streptozotocin-diabetic rats.
    Sako Y, Grill VE.
    Metabolism; 1992 Jul 20; 41(7):738-43. PubMed ID: 1535679
    [Abstract] [Full Text] [Related]

  • 13. Dynamics of glucose-induced insulin release during the spontaneous remission of streptozocin diabetes induced in the newborn rat.
    Portha B, Kergoat M.
    Diabetes; 1985 Jun 20; 34(6):574-9. PubMed ID: 3891470
    [Abstract] [Full Text] [Related]

  • 14. Insulin treatment improves glucose-induced insulin release in rats with NIDDM induced by streptozocin.
    Kergoat M, Bailbe D, Portha B.
    Diabetes; 1987 Aug 20; 36(8):971-7. PubMed ID: 3297892
    [Abstract] [Full Text] [Related]

  • 15. Abnormal regulation by glucose of somatostatin secretion in the perfused pancreas of NIDDM rats.
    Ostenson CG, Efendic S, Grill V.
    Pancreas; 1990 May 20; 5(3):347-53. PubMed ID: 1971441
    [Abstract] [Full Text] [Related]

  • 16. New combination therapy of gliclazide and quercetin for protection against STZ-induced diabetic rats.
    Abdelkader NF, Eitah HE, Maklad YA, Gamaleldin AA, Badawi MA, Kenawy SA.
    Life Sci; 2020 Apr 15; 247():117458. PubMed ID: 32092333
    [Abstract] [Full Text] [Related]

  • 17. Abnormal insulin secretion in a streptozocin model of diabetes. Effects of insulin treatment.
    Leahy JL, Bonner-Weir S, Weir GC.
    Diabetes; 1985 Jul 15; 34(7):660-6. PubMed ID: 2408948
    [Abstract] [Full Text] [Related]

  • 18. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
    Tourrel C, Bailbé D, Meile MJ, Kergoat M, Portha B.
    Diabetes; 2001 Jul 15; 50(7):1562-70. PubMed ID: 11423477
    [Abstract] [Full Text] [Related]

  • 19. Relation of insulin deficiency to impaired insulin action in NIDDM adult rats given streptozocin as neonates.
    Blondel O, Bailbé D, Portha B.
    Diabetes; 1989 May 15; 38(5):610-7. PubMed ID: 2523831
    [Abstract] [Full Text] [Related]

  • 20. Abnormal calcium handling by perifused pancreatic islets from neonatal streptozotocin diabetic model rats.
    Hashimoto N, Kanatsuka A, Makino H, Sakurada M, Iwaoka H, Yoshida S, Horie H.
    Metabolism; 1987 Sep 15; 36(9):827-33. PubMed ID: 3306276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.